Share Price and Basic Stock Data
Last Updated: December 31, 2025, 9:06 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
BL Kashyap & Sons Ltd operates in the construction, contracting, and engineering sector, with a current market capitalization of ₹1,254 Cr and a share price of ₹55.8. The company has shown a fluctuating revenue trend, reporting sales of ₹1,110 Cr for the fiscal year ending March 2023, a slight decline from ₹1,158 Cr in the previous fiscal year. However, the trailing twelve months (TTM) revenue rose to ₹1,228 Cr, indicating recovery as the company navigates through challenging market conditions. Quarterly sales have also demonstrated variability; for example, sales in September 2023 were ₹326.62 Cr, a notable increase from ₹252.77 Cr in December 2022. This upward trajectory in sales is promising, particularly as the company is expected to generate ₹1,245 Cr in sales for FY 2024, although this is lower than the anticipated ₹1,154 Cr for FY 2025. The construction sector in India is projected to grow, driven by government infrastructure initiatives, which may benefit BL Kashyap if they can effectively capitalize on these opportunities.
Profitability and Efficiency Metrics
Profitability metrics for BL Kashyap & Sons Ltd reflect a challenging operational environment. The operating profit margin (OPM) stood at 5.76%, indicating tight margins typical of the construction industry. In FY 2023, the operating profit was reported at ₹98 Cr, with expenses amounting to ₹1,012 Cr. Notably, the company recorded a net profit of zero for the same period, reflecting significant challenges in managing costs and generating earnings. The interest coverage ratio (ICR) was reported at 1.93x, which suggests that the company can cover its interest obligations, but the ratio remains low compared to industry standards. The return on equity (ROE) was a mere 2%, and return on capital employed (ROCE) was 8.08%, both indicating that the company has room for improvement in utilizing its capital effectively. The cash conversion cycle (CCC) of 113 days suggests inefficiencies in working capital management, impacting overall profitability.
Balance Sheet Strength and Financial Ratios
BL Kashyap’s balance sheet reflects a mixed picture of financial health. The total borrowings stood at ₹309 Cr against reserves of ₹503 Cr, indicating a leverage ratio that is relatively manageable given the interest coverage ratio of 1.93x. The company’s current ratio was reported at 1.40x, suggesting adequate short-term liquidity, while the quick ratio at 1.17x indicates a reasonable ability to meet immediate obligations. The price-to-book value (P/BV) ratio was recorded at 2.21x, which is higher than typical sector averages, suggesting that the stock might be overvalued compared to its net assets. The total debt-to-equity ratio of 0.60x indicates a conservative capital structure, yet the company needs to focus on improving profitability to enhance its equity base. The return on assets (ROA) was low at 1.81%, highlighting a need for better asset utilization in generating profits.
Shareholding Pattern and Investor Confidence
The shareholding pattern of BL Kashyap & Sons Ltd reveals a strong promoter holding of 61.70%, which indicates a robust commitment from the founding family. However, foreign institutional investors (FIIs) have a minimal stake of 0.34%, and domestic institutional investors (DIIs) hold 0.59%, suggesting limited institutional interest in the company. The public shareholding stands at 37.37%, with the number of shareholders recorded at 44,066, indicating a broad base of retail investors. The lack of significant foreign investment could be a concern, reflecting investor apprehension regarding the company’s growth prospects. Over the past year, the promoter’s stake has gradually increased, which may signal confidence in the company’s long-term strategy. However, the low institutional interest may hinder the stock’s liquidity and overall market perception, impacting its ability to attract further investments.
Outlook, Risks, and Final Insight
Looking ahead, BL Kashyap & Sons Ltd faces both opportunities and challenges. The anticipated growth in India’s infrastructure sector could provide a boost, but the company must improve its profitability metrics to attract investor confidence. Key risks include rising input costs, which could further squeeze margins, and the potential for project delays that are common in the construction industry. Additionally, with a CCC of 113 days, the company must enhance its working capital management to improve cash flow. If BL Kashyap can effectively leverage its strong promoter support and capitalize on growth opportunities while managing costs, it may position itself favorably in a recovering market. Conversely, failure to address profitability concerns could lead to ongoing investor skepticism and limit its growth trajectory in the competitive landscape of construction and engineering in India.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Engineering and Projects Ltd | 51.6 Cr. | 33.4 | 49.9/22.5 | 4.92 | 39.4 | 0.00 % | 20.5 % | 25.9 % | 10.0 |
| Modis Navnirman Ltd | 680 Cr. | 343 | 409/220 | 82.9 | 46.5 | 0.00 % | 12.9 % | 9.88 % | 10.0 |
| Modulex Construction Technologies Ltd | 152 Cr. | 21.9 | 35.7/18.0 | 44.7 | 0.00 % | 2.51 % | 1.54 % | 10.0 | |
| MPDL Ltd | 33.1 Cr. | 44.7 | 92.0/38.0 | 127 | 0.00 % | 2.87 % | 4.16 % | 10.0 | |
| IITL Projects Ltd | 33.3 Cr. | 66.7 | 77.9/47.1 | 2.12 | 0.00 % | 16.6 % | % | 10.0 | |
| Industry Average | 17,568.43 Cr | 251.27 | 76.25 | 138.29 | 0.16% | 16.34% | 21.32% | 21.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 292.70 | 252.77 | 275.92 | 252.73 | 326.62 | 324.00 | 341.18 | 350.31 | 267.28 | 241.86 | 294.18 | 336.42 | 355.13 |
| Expenses | 272.00 | 230.76 | 252.75 | 228.18 | 297.56 | 300.44 | 308.10 | 318.59 | 247.10 | 235.65 | 286.95 | 310.47 | 334.66 |
| Operating Profit | 20.70 | 22.01 | 23.17 | 24.55 | 29.06 | 23.56 | 33.08 | 31.72 | 20.18 | 6.21 | 7.23 | 25.95 | 20.47 |
| OPM % | 7.07% | 8.71% | 8.40% | 9.71% | 8.90% | 7.27% | 9.70% | 9.05% | 7.55% | 2.57% | 2.46% | 7.71% | 5.76% |
| Other Income | 5.13 | 8.56 | -30.08 | 2.71 | 1.02 | 0.89 | 7.61 | 9.31 | 11.67 | 8.89 | 14.91 | 2.71 | 1.95 |
| Interest | 12.76 | 12.16 | 13.46 | 10.97 | 10.59 | 11.79 | 15.48 | 11.39 | 13.73 | 10.09 | 12.28 | 10.68 | 10.89 |
| Depreciation | 2.54 | 2.40 | 2.29 | 2.43 | 2.52 | 2.63 | 2.78 | 2.89 | 3.12 | 3.13 | 3.27 | 3.40 | 3.81 |
| Profit before tax | 10.53 | 16.01 | -22.66 | 13.86 | 16.97 | 10.03 | 22.43 | 26.75 | 15.00 | 1.88 | 6.59 | 14.58 | 7.72 |
| Tax % | 45.49% | -128.54% | 40.91% | 28.21% | 29.29% | 31.01% | -5.53% | 24.34% | 37.53% | 40.96% | 149.47% | 25.58% | 211.66% |
| Net Profit | 5.74 | 36.59 | -31.93 | 9.96 | 11.99 | 6.91 | 23.66 | 20.25 | 9.38 | 1.11 | -3.26 | 10.85 | -8.62 |
| EPS in Rs | 0.25 | 1.62 | -1.42 | 0.44 | 0.53 | 0.31 | 1.05 | 0.90 | 0.42 | 0.05 | -0.14 | 0.48 | -0.38 |
Last Updated: December 27, 2025, 11:05 pm
Below is a detailed analysis of the quarterly data for BL Kashyap & Sons Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 355.13 Cr.. The value appears strong and on an upward trend. It has increased from 336.42 Cr. (Jun 2025) to 355.13 Cr., marking an increase of 18.71 Cr..
- For Expenses, as of Sep 2025, the value is 334.66 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 310.47 Cr. (Jun 2025) to 334.66 Cr., marking an increase of 24.19 Cr..
- For Operating Profit, as of Sep 2025, the value is 20.47 Cr.. The value appears to be declining and may need further review. It has decreased from 25.95 Cr. (Jun 2025) to 20.47 Cr., marking a decrease of 5.48 Cr..
- For OPM %, as of Sep 2025, the value is 5.76%. The value appears to be declining and may need further review. It has decreased from 7.71% (Jun 2025) to 5.76%, marking a decrease of 1.95%.
- For Other Income, as of Sep 2025, the value is 1.95 Cr.. The value appears to be declining and may need further review. It has decreased from 2.71 Cr. (Jun 2025) to 1.95 Cr., marking a decrease of 0.76 Cr..
- For Interest, as of Sep 2025, the value is 10.89 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.68 Cr. (Jun 2025) to 10.89 Cr., marking an increase of 0.21 Cr..
- For Depreciation, as of Sep 2025, the value is 3.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.40 Cr. (Jun 2025) to 3.81 Cr., marking an increase of 0.41 Cr..
- For Profit before tax, as of Sep 2025, the value is 7.72 Cr.. The value appears to be declining and may need further review. It has decreased from 14.58 Cr. (Jun 2025) to 7.72 Cr., marking a decrease of 6.86 Cr..
- For Tax %, as of Sep 2025, the value is 211.66%. The value appears to be increasing, which may not be favorable. It has increased from 25.58% (Jun 2025) to 211.66%, marking an increase of 186.08%.
- For Net Profit, as of Sep 2025, the value is -8.62 Cr.. The value appears to be declining and may need further review. It has decreased from 10.85 Cr. (Jun 2025) to -8.62 Cr., marking a decrease of 19.47 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.38. The value appears to be declining and may need further review. It has decreased from 0.48 (Jun 2025) to -0.38, marking a decrease of 0.86.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:07 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,349 | 834 | 860 | 924 | 1,012 | 769 | 820 | 762 | 1,158 | 1,110 | 1,245 | 1,154 | 1,228 |
| Expenses | 1,296 | 816 | 792 | 834 | 927 | 713 | 799 | 699 | 1,067 | 1,012 | 1,134 | 1,088 | 1,168 |
| Operating Profit | 53 | 19 | 68 | 89 | 85 | 57 | 21 | 63 | 90 | 98 | 110 | 65 | 60 |
| OPM % | 4% | 2% | 8% | 10% | 8% | 7% | 3% | 8% | 8% | 9% | 9% | 6% | 5% |
| Other Income | -65 | 31 | 23 | 0 | 31 | 5 | -22 | 7 | 41 | -16 | 12 | 45 | 28 |
| Interest | 97 | 81 | 82 | 83 | 77 | 59 | 69 | 59 | 55 | 51 | 49 | 47 | 44 |
| Depreciation | 23 | 47 | 21 | 13 | 12 | 12 | 12 | 11 | 10 | 10 | 10 | 12 | 14 |
| Profit before tax | -132 | -78 | -12 | -6 | 27 | -10 | -82 | -1 | 66 | 21 | 63 | 50 | 31 |
| Tax % | -36% | -26% | -48% | -181% | 23% | -34% | -23% | 8,490% | 33% | -7% | 17% | 45% | |
| Net Profit | -85 | -58 | -6 | 5 | 21 | -6 | -63 | -58 | 44 | 22 | 53 | 27 | 0 |
| EPS in Rs | -4.14 | -2.82 | -0.29 | 0.24 | 0.98 | -0.28 | -2.79 | -2.59 | 1.95 | 0.98 | 2.33 | 1.22 | 0.01 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 31.76% | 89.66% | 183.33% | 320.00% | -128.57% | -950.00% | 7.94% | 175.86% | -50.00% | 140.91% | -49.06% |
| Change in YoY Net Profit Growth (%) | 0.00% | 57.89% | 93.68% | 136.67% | -448.57% | -821.43% | 957.94% | 167.93% | -225.86% | 190.91% | -189.97% |
BL Kashyap & Sons Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 7% |
| 3 Years: | 0% |
| TTM: | -15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 22% |
| 3 Years: | -2% |
| TTM: | -72% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 55% |
| 3 Years: | 39% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 6% |
| 3 Years: | 8% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:31 pm
Balance Sheet
Last Updated: December 10, 2025, 3:54 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 21 | 21 | 21 | 22 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 |
| Reserves | 444 | 384 | 379 | 414 | 476 | 493 | 436 | 357 | 400 | 422 | 474 | 501 | 503 |
| Borrowings | 682 | 762 | 797 | 745 | 605 | 552 | 520 | 519 | 380 | 320 | 310 | 316 | 309 |
| Other Liabilities | 695 | 596 | 637 | 595 | 645 | 756 | 839 | 622 | 629 | 531 | 606 | 676 | 774 |
| Total Liabilities | 1,841 | 1,762 | 1,833 | 1,774 | 1,748 | 1,824 | 1,818 | 1,520 | 1,432 | 1,295 | 1,412 | 1,516 | 1,608 |
| Fixed Assets | 140 | 90 | 99 | 431 | 414 | 412 | 311 | 236 | 230 | 133 | 154 | 192 | 220 |
| CWIP | 117 | 130 | 139 | 95 | 97 | 94 | 95 | -0 | -0 | -0 | 2 | 0 | 0 |
| Investments | 299 | 299 | 301 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1,285 | 1,244 | 1,294 | 1,247 | 1,236 | 1,316 | 1,412 | 1,284 | 1,202 | 1,162 | 1,256 | 1,323 | 1,388 |
| Total Assets | 1,841 | 1,762 | 1,833 | 1,774 | 1,748 | 1,824 | 1,818 | 1,520 | 1,432 | 1,295 | 1,412 | 1,516 | 1,608 |
Below is a detailed analysis of the balance sheet data for BL Kashyap & Sons Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 23.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00 Cr..
- For Reserves, as of Sep 2025, the value is 503.00 Cr.. The value appears strong and on an upward trend. It has increased from 501.00 Cr. (Mar 2025) to 503.00 Cr., marking an increase of 2.00 Cr..
- For Borrowings, as of Sep 2025, the value is 309.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 316.00 Cr. (Mar 2025) to 309.00 Cr., marking a decrease of 7.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 774.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 676.00 Cr. (Mar 2025) to 774.00 Cr., marking an increase of 98.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,608.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,516.00 Cr. (Mar 2025) to 1,608.00 Cr., marking an increase of 92.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 220.00 Cr.. The value appears strong and on an upward trend. It has increased from 192.00 Cr. (Mar 2025) to 220.00 Cr., marking an increase of 28.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,388.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,323.00 Cr. (Mar 2025) to 1,388.00 Cr., marking an increase of 65.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,608.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,516.00 Cr. (Mar 2025) to 1,608.00 Cr., marking an increase of 92.00 Cr..
Notably, the Reserves (503.00 Cr.) exceed the Borrowings (309.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -629.00 | -743.00 | -729.00 | -656.00 | -520.00 | -495.00 | -499.00 | -456.00 | -290.00 | -222.00 | -200.00 | -251.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 107 | 169 | 187 | 156 | 127 | 176 | 171 | 210 | 110 | 138 | 111 | 138 |
| Inventory Days | 259 | 414 | 384 | 333 | 261 | 372 | 347 | 201 | 240 | 105 | 130 | |
| Days Payable | 150 | 188 | 163 | 118 | 152 | 170 | 179 | 116 | 140 | 136 | 154 | |
| Cash Conversion Cycle | 215 | 396 | 407 | 371 | 236 | 378 | 339 | 210 | 195 | 238 | 80 | 113 |
| Working Capital Days | 37 | 73 | 94 | 13 | -19 | -7 | 41 | 84 | 41 | 64 | 68 | 94 |
| ROCE % | 4% | 0% | 6% | 7% | 9% | 5% | 2% | 8% | 10% | 14% | 14% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 1.22 | 2.33 | 0.98 | 1.95 | -2.59 |
| Diluted EPS (Rs.) | 1.22 | 2.33 | 0.98 | 1.95 | -2.59 |
| Cash EPS (Rs.) | 1.77 | 2.79 | 1.41 | 2.41 | -2.10 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 23.23 | 22.02 | 19.73 | 18.76 | 16.82 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 23.23 | 22.02 | 19.73 | 18.76 | 16.82 |
| Revenue From Operations / Share (Rs.) | 51.17 | 55.20 | 49.24 | 51.34 | 33.81 |
| PBDIT / Share (Rs.) | 4.06 | 5.43 | 5.22 | 4.10 | 3.90 |
| PBIT / Share (Rs.) | 3.51 | 4.97 | 4.79 | 3.64 | 3.41 |
| PBT / Share (Rs.) | 2.23 | 2.81 | 0.91 | 2.92 | -0.03 |
| Net Profit / Share (Rs.) | 1.22 | 2.33 | 0.98 | 1.95 | -2.59 |
| NP After MI And SOA / Share (Rs.) | 1.22 | 2.33 | 0.98 | 1.95 | -2.59 |
| PBDIT Margin (%) | 7.92 | 9.84 | 10.60 | 7.99 | 11.54 |
| PBIT Margin (%) | 6.85 | 9.00 | 9.72 | 7.09 | 10.09 |
| PBT Margin (%) | 4.35 | 5.08 | 1.85 | 5.69 | -0.08 |
| Net Profit Margin (%) | 2.38 | 4.22 | 1.99 | 3.79 | -7.66 |
| NP After MI And SOA Margin (%) | 2.38 | 4.22 | 1.99 | 3.79 | -7.66 |
| Return on Networth / Equity (%) | 5.24 | 10.58 | 4.97 | 10.39 | -15.40 |
| Return on Capital Employeed (%) | 11.60 | 17.16 | 18.33 | 12.39 | 10.79 |
| Return On Assets (%) | 1.81 | 3.72 | 1.70 | 3.06 | -3.84 |
| Long Term Debt / Equity (X) | 0.07 | 0.06 | 0.08 | 0.15 | 0.29 |
| Total Debt / Equity (X) | 0.60 | 0.62 | 0.71 | 0.86 | 1.11 |
| Asset Turnover Ratio (%) | 0.78 | 0.91 | 0.81 | 0.76 | 0.44 |
| Current Ratio (X) | 1.40 | 1.37 | 1.36 | 1.21 | 1.27 |
| Quick Ratio (X) | 1.17 | 0.71 | 0.87 | 0.77 | 0.82 |
| Inventory Turnover Ratio (X) | 3.35 | 1.57 | 1.55 | 1.84 | 1.14 |
| Interest Coverage Ratio (X) | 1.93 | 2.51 | 2.29 | 1.69 | 1.48 |
| Interest Coverage Ratio (Post Tax) (X) | 1.19 | 2.08 | 2.13 | 1.10 | 0.32 |
| Enterprise Value (Cr.) | 1439.17 | 1822.80 | 959.52 | 931.69 | 821.69 |
| EV / Net Operating Revenue (X) | 1.25 | 1.46 | 0.86 | 0.80 | 1.08 |
| EV / EBITDA (X) | 15.73 | 14.88 | 8.15 | 10.07 | 9.34 |
| MarketCap / Net Operating Revenue (X) | 1.00 | 1.24 | 0.63 | 0.51 | 0.55 |
| Price / BV (X) | 2.21 | 3.12 | 1.57 | 1.41 | 1.12 |
| Price / Net Operating Revenue (X) | 1.00 | 1.24 | 0.63 | 0.51 | 0.55 |
| EarningsYield | 0.02 | 0.03 | 0.03 | 0.07 | -0.13 |
After reviewing the key financial ratios for BL Kashyap & Sons Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 5. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 5. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 3. It has decreased from 2.79 (Mar 24) to 1.77, marking a decrease of 1.02.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.23. It has increased from 22.02 (Mar 24) to 23.23, marking an increase of 1.21.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.23. It has increased from 22.02 (Mar 24) to 23.23, marking an increase of 1.21.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 51.17. It has decreased from 55.20 (Mar 24) to 51.17, marking a decrease of 4.03.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 4.06. This value is within the healthy range. It has decreased from 5.43 (Mar 24) to 4.06, marking a decrease of 1.37.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.51. This value is within the healthy range. It has decreased from 4.97 (Mar 24) to 3.51, marking a decrease of 1.46.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.23. This value is within the healthy range. It has decreased from 2.81 (Mar 24) to 2.23, marking a decrease of 0.58.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
- For PBDIT Margin (%), as of Mar 25, the value is 7.92. This value is below the healthy minimum of 10. It has decreased from 9.84 (Mar 24) to 7.92, marking a decrease of 1.92.
- For PBIT Margin (%), as of Mar 25, the value is 6.85. This value is below the healthy minimum of 10. It has decreased from 9.00 (Mar 24) to 6.85, marking a decrease of 2.15.
- For PBT Margin (%), as of Mar 25, the value is 4.35. This value is below the healthy minimum of 10. It has decreased from 5.08 (Mar 24) to 4.35, marking a decrease of 0.73.
- For Net Profit Margin (%), as of Mar 25, the value is 2.38. This value is below the healthy minimum of 5. It has decreased from 4.22 (Mar 24) to 2.38, marking a decrease of 1.84.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.38. This value is below the healthy minimum of 8. It has decreased from 4.22 (Mar 24) to 2.38, marking a decrease of 1.84.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.24. This value is below the healthy minimum of 15. It has decreased from 10.58 (Mar 24) to 5.24, marking a decrease of 5.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.60. This value is within the healthy range. It has decreased from 17.16 (Mar 24) to 11.60, marking a decrease of 5.56.
- For Return On Assets (%), as of Mar 25, the value is 1.81. This value is below the healthy minimum of 5. It has decreased from 3.72 (Mar 24) to 1.81, marking a decrease of 1.91.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 0.2. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.60. This value is within the healthy range. It has decreased from 0.62 (Mar 24) to 0.60, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.78. It has decreased from 0.91 (Mar 24) to 0.78, marking a decrease of 0.13.
- For Current Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 1.5. It has increased from 1.37 (Mar 24) to 1.40, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has increased from 0.71 (Mar 24) to 1.17, marking an increase of 0.46.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.35. This value is below the healthy minimum of 4. It has increased from 1.57 (Mar 24) to 3.35, marking an increase of 1.78.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.93. This value is below the healthy minimum of 3. It has decreased from 2.51 (Mar 24) to 1.93, marking a decrease of 0.58.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 3. It has decreased from 2.08 (Mar 24) to 1.19, marking a decrease of 0.89.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,439.17. It has decreased from 1,822.80 (Mar 24) to 1,439.17, marking a decrease of 383.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 1.46 (Mar 24) to 1.25, marking a decrease of 0.21.
- For EV / EBITDA (X), as of Mar 25, the value is 15.73. This value exceeds the healthy maximum of 15. It has increased from 14.88 (Mar 24) to 15.73, marking an increase of 0.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 1.24 (Mar 24) to 1.00, marking a decrease of 0.24.
- For Price / BV (X), as of Mar 25, the value is 2.21. This value is within the healthy range. It has decreased from 3.12 (Mar 24) to 2.21, marking a decrease of 0.91.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 1.24 (Mar 24) to 1.00, marking a decrease of 0.24.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in BL Kashyap & Sons Ltd:
- Net Profit Margin: 2.38%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.6% (Industry Average ROCE: 16.34%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.24% (Industry Average ROE: 21.32%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.17
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 76.25)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.6
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.38%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Construction, Contracting & Engineering | 409, 4th Floor, New Delhi Delhi 110025 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vinod Kashyap | Chairman |
| Mr. Vineet Kashyap | Managing Director |
| Mr. Vikram Kashyap | Joint Managing Director |
| Mr. Vivek Talwar | Independent Director |
| Mr. Settihalli Basavaraj | Independent Director |
| Mrs. Neelam Naresh Kothari | Independent Director |
| Mr. Gopinath Ambadithody | Independent Director |
| Mr. Vishal Sharat Ohri | Nominee Director |
FAQ
What is the intrinsic value of BL Kashyap & Sons Ltd?
BL Kashyap & Sons Ltd's intrinsic value (as of 31 December 2025) is ₹5.70 which is 89.29% lower the current market price of ₹53.20, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,191 Cr. market cap, FY2025-2026 high/low of ₹84.7/42.7, reserves of ₹503 Cr, and liabilities of ₹1,608 Cr.
What is the Market Cap of BL Kashyap & Sons Ltd?
The Market Cap of BL Kashyap & Sons Ltd is 1,191 Cr..
What is the current Stock Price of BL Kashyap & Sons Ltd as on 31 December 2025?
The current stock price of BL Kashyap & Sons Ltd as on 31 December 2025 is ₹53.2.
What is the High / Low of BL Kashyap & Sons Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of BL Kashyap & Sons Ltd stocks is ₹84.7/42.7.
What is the Stock P/E of BL Kashyap & Sons Ltd?
The Stock P/E of BL Kashyap & Sons Ltd is .
What is the Book Value of BL Kashyap & Sons Ltd?
The Book Value of BL Kashyap & Sons Ltd is 23.3.
What is the Dividend Yield of BL Kashyap & Sons Ltd?
The Dividend Yield of BL Kashyap & Sons Ltd is 0.00 %.
What is the ROCE of BL Kashyap & Sons Ltd?
The ROCE of BL Kashyap & Sons Ltd is 8.08 %.
What is the ROE of BL Kashyap & Sons Ltd?
The ROE of BL Kashyap & Sons Ltd is 2.00 %.
What is the Face Value of BL Kashyap & Sons Ltd?
The Face Value of BL Kashyap & Sons Ltd is 1.00.